CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/64258/1331_H7_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/64258/144292_A_4_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39796/84042_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1S | Calcium channel, voltage-dependent, L type, alpha 1S subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/56815/ihc_cell_selected_60x60.jpg) | ![](/images/48892/130229_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CATSPER4 | Cation channel, sperm associated 4 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/45257/158037_A_1_8_selected_60x60.jpg) | ![](/images/45257/142022_A_1_6_rna_selected_60x60.jpg) | Tissue enriched |
HCN1 | Hyperpolarization activated cyclic nucleotide-gated potassium channel 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19195/108171_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21516/109609_B_7_2_rna_selected_60x60.jpg) | Group enriched |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/42434/134744_A_1_8_selected_60x60.jpg) | ![](/images/42434/134323_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/47634/ihc_cell_selected_60x60.jpg) | ![](/images/47634/111871_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/19664/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19664/45838_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/14738/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4678/18243_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/40024/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40024/93063_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
KCNH1 | Potassium voltage-gated channel, subfamily H (eag-related), member 1 | Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19445/151973_B_7_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/26962/ihc_cell_selected_60x60.jpg) | ![](/images/26962/65936_A_1_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/14722/ihc_cell_selected_60x60.jpg) | ![](/images/17353/40077_B_8_6_rna_selected_60x60.jpg) | Group enriched |
KCNK1 | Potassium channel, subfamily K, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | ![](/images/16049/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16049/38206_A_9_7_rna_selected_60x60.jpg) | Mixed |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48553/123855_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
MCOLN1 | Mucolipin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/31763/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/31763/72216_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/19114/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19114/43843_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22567/52670_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
TPCN2 | Two pore segment channel 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/16561/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27080/57948_B_9_8_rna_selected_60x60.jpg) | Expressed in all |
TRPC1 | Transient receptor potential cation channel, subfamily C, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images/21130/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/9387/30894_B_9_2_rna_selected_60x60.jpg) | Mixed |
TRPM4 | Transient receptor potential cation channel, subfamily M, member 4 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | ![](/images_static/rna_center.gif) | ![](/images/41169/90326_B_9_2_rna_selected_60x60.jpg) | Mixed |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42115/90698_A_5_3_rna_selected_60x60.jpg) | Group enriched |